Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TYO/2183 stock hub

TYO/2183 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TYO/2183is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
5.5B
Tokyo Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TYO/2183
In the news

Latest news · TYO/2183

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.7P50 15.8P75 21.7
Trailing P/En/a
P25 11.7P50 15.2P75 22.3
ROEn/a
P25 -1.6P50 7.1P75 11.9
ROIC-54.4
P25 -0.6P50 6.2P75 14.3
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TYO/2183 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
180
Groups with data
11
Currency
JPY
Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Japan
Country code
JP
Employees
598
Employees Change
-64%
Employees Change Percent
-9.67
Enterprise value
JPY 2.7B
Exchange
Tokyo Stock Exchange
Financial currency
JPY
First seen
2026-05-10
Industry
Biotechnology
Isin
JP3974530002
Last refreshed
2026-05-10
Market cap
JPY 5.5B
Price
JPY 244
Price currency
JPY
Rev Per Employee
15,584,229.1x
Sector
Healthcare
Sic
8731
Symbol
tyo/2183
Website
https://www.linical.com/ja

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-32.18%
EV Earnings
-1.53x
EV/Sales
0.29x
P/B ratio
0.97x
P/S ratio
0.59x
PE Ratio10 Y
33.7x
PE Ratio5 Y
22.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

14
MetricValue
Gross Profit
JPY 1.6B
Gross Profit Growth
-38.8%
Gross Profit Growth Q
-92.82%
Gross Profit Growth3 Y
-25.38%
Gross Profit Growth5 Y
-9.99%
Net Income
JPY -1.8B
Net Income Growth Years
0%
Pretax Margin
-15.94%
Profit Per Employee
JPY -3M
Roa5y
2.3
ROCE
-20.52
Roe5y
6.84
ROIC
-54.36
Roic5y
7.49

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

14
MetricValue
Cagr10y
-17.95%
Cagr15y
4.97%
Cagr1y
-15.6%
Cagr3y
-26.86%
Cagr5y
-16.94%
Div CAGR10
-2.21%
Div CAGR3
-18.9%
Div CAGR5
-10.59%
EPS Growth Years
0
Revenue Growth
-15.38x
Revenue Growth Q
-21.77x
Revenue Growth Years
0x
Revenue Growth3 Y
-8.56x
Revenue Growth5 Y
-1.91x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
JPY 0.59
Assets
JPY 14B
Cash
JPY 5.2B
Current Assets
JPY 9.3B
Current Liabilities
JPY 6.5B
Debt
JPY 2.4B
Debt Equity
JPY 0.42
Equity
JPY 5.7B
Interest Coverage
-86.03
Liabilities
JPY 8.3B
Long Term Assets
JPY 4.7B
Long Term Liabilities
JPY 1.8B
Net Cash
JPY 2.8B
Net Cash By Market Cap
JPY 50.79
Net Cash Growth
-35.49%
Net Debt Equity
JPY -0.49
Tangible Book Value
JPY 2.5B
Tangible Book Value Per Share
JPY 112
WACC
4.61

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
1.41
Net Working Capital
JPY -1.1B
Quick ratio
1.15
Working Capital
JPY 2.7B
Working Capital Turnover
JPY 2.71

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

8
MetricValue
Dividend Growth
-50%
Dividend Growth Years
2%
Dividend per share
JPY 16
Dividend Years
18
Dividend Yield
6.56%
Ex Div Date
2026-03-30
Last Dividend
JPY 8
Payout Frequency
Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-86.16%
1Y total return
-15.59%
200-day SMA
313.5
3Y total return
-60.88%
50-day SMA
277.3
50-day SMA vs 200-day SMA
50under200
5Y total return
-60.47%
All Time High
2,584
All Time High Change
-90.56%
All Time High Date
2018-07-18
All Time Low
111
All Time Low Change
119.82%
All Time Low Date
2011-09-26
ATR
4.03
Beta
0.38
Beta1y
0.53
Beta2y
0.6
Ch YTD
-16.72
High
244
High52
363
High52 Date
2025-08-14
High52ch
-32.78%
Low
242
Low52
242
Low52 Date
2026-05-08
Low52ch
0.83%
Ma50ch
-12%
Price vs 200-day SMA
-22.18%
RSI
23.11
RSI Monthly
27.53
RSI Weekly
24.83
Sharpe ratio
-0.63x
Sortino ratio
-0.57
Total Return
6.56%
Tr YTD
-14.15
Tr15y
107.01%
Tr1m
-4.31%
Tr1w
-0.81%
Tr3m
-20.65%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
JPY -1.5B
Operating margin
-16.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

5
MetricValue
Float
10,628,031%
Shares Insiders
49.36%
Shares Institutions
1.57%
Shares Out
22,586,431
Shares Qo Q
0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

47
MetricValue
Average Volume
22,150x
Bv Per Share
251
Ch10y
-88.77
Ch15y
56.41
Ch1m
-4.31
Ch1w
-0.81
Ch1y
-18.12
Ch3m
-23.03
Ch3y
-65.19
Ch5y
-66.06
Ch6m
-30.48
Change
0%
Change From Open
0.41
Close
244
Days Gap
-0.41
Depreciation Amortization
547,250,000
Dollar Volume
3,245,200
Earnings Date
2026-05-15
EBIT
JPY -1.5B
EBITDA
JPY -981M
EPS
JPY -78.51
F Score
1
Fiscal Year End
March
Founded
2,005
Goodwill
3,065,994,000
Income Tax
JPY 287.8M
Is Primary Listing
1
Last Earnings Date
2026-02-13
Last Report Date
2025-12-31
Last Split Date
2015-12-28
Last Split Type
Forward
Ma150
305.7
Ma150ch
-20.2%
Ma20
251.9
Ma20ch
-3.12%
Next Earnings Date
2026-05-15
Open
243
Payment Date
2026-06-11
Position In Range
100
Ppne
381,871,000
Price Date
2026-05-08
Ptbv Ratio
2.19
Relative Volume
0.6x
Revenue
9,319,369,000x
Tax By Revenue
3.09x
Tr6m
-28.34%
Volume
13,300
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

TYO/2183 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+6.6%
$16.0 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
-10.6%
2 consecutive years of growth
Total shareholder yield
+6.6%
Next ex-dividend date: 2026-03-30
Performance

TYO/2183 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-15.6%
S&P 500 1Y: n/a
3Y total return
-60.9%
S&P 500 3Y: n/a
5Y total return
-60.5%
S&P 500 5Y: n/a
10Y total return
-86.2%
S&P 500 10Y: n/a
Ownership

Who owns TYO/2183?

Insider, institutional, and short-interest positioning.

Institutional ownership
+1.6%
Share of float held by funds and institutions
Insider ownership
+49.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

TYO/2183 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
23.1
Below 30: short-term oversold
Price vs 200-day MA
-22.2%
50/200-day relationship not available
Beta (5Y)
0.38
Less volatile than the market
Sharpe ratio
-0.63
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TYO/2183

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tyo/2183 stock rating?

tyo/2183 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tyo/2183 analysis?

The full report lives at /stocks/tyo/2183/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tyo/2183?

The latest report frames tyo/2183 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tyo/2183 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

tyo/2183 stock profile: metrics, valuation and analysis | ИИ-агент фондового рынка